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Background
Allergic rhinitis (AR) is a complex inflammatory disorder
where antigen presenting cells (APCs) are believed to
activate allergen-specific CD4+ T cells at the site of aller-
gen exposure. By sorting cells from the nasal mucosa in
an experimental model of AR we have found, at the tran-
scriptome level, that the total population of CD45+
HLA-DR+ cells showed signs of activation concomitant
with an activated Th2 signature in purified CD4+ T cells.
Bone marrow-derived APCs consists of many distinct
subsets including dendritic cells (DC) and monocytes/
macrophages. The aim of this work was to study the traf-
ficking of various APC subsets during the allergic
inflammation.
Material and methods
Six AR-patients were challenged locally once a day with
grass-pollen extract for 7 days out of the season. Daily
symptoms were recorded using visual analogue scale.
Mucosal biopsies were obtained before challenge and at
day 3 and day 8. Multi-colour immunostaining in situ
using a panel of antibodies was performed to determine
the density of APC subsets. The density of eosinophils
was also recorded.
Results
All patients experienced typical symptoms throughout
the challenge period and the density of tissue eosinophils
was significantly increased at day 3 and 8 compared with
baseline. At baseline HLA-DR+ cells could be clearly
divided into two distinct subsets: the majority of cells
were positive for the monocyte/macrophage marker
CD14 whereas a minor population expressed the DC
marker CD1c, but were negative for CD14. During the
course of challenge a ~5-fold increase in the number of
CD14+HLA-DR+ cells was observed at both day 3 and 7
(mean number of cells/mm2 76, 410 and 379 at baseline,
day 3 and 7, respectively). The density of CD1c+ DCs, on
the other hand, was not different from baseline to day 3,
but showed a significant increase at day 7 (median num-
ber of cells/mm2 40 vs 120).
Conclusion
We found a significant increase in the density of both
CD14+ monocytes/macrophages and CD1c+DCs, but the
increase of CD14+APCs appears earlier. CD14 is
expressed on both macrophages and monocytes but in the
setting of acute inflammatory reaction our findings
strongly suggests that the increase is caused by an early
recruitment of circulating CD14+ monocytes to the chal-
lenged site. This is in accordance with recent results in
asthma mouse models lending further support to the
notion that CD14+ “inflammatory” monocytes play a
direct role in human airway allergy.
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